BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 21307168)

  • 1. β-catenin tyrosine 654 phosphorylation increases Wnt signalling and intestinal tumorigenesis.
    van Veelen W; Le NH; Helvensteijn W; Blonden L; Theeuwes M; Bakker ER; Franken PF; van Gurp L; Meijlink F; van der Valk MA; Kuipers EJ; Fodde R; Smits R
    Gut; 2011 Sep; 60(9):1204-12. PubMed ID: 21307168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The orphan receptor TR3 suppresses intestinal tumorigenesis in mice by downregulating Wnt signalling.
    Chen HZ; Liu QF; Li L; Wang WJ; Yao LM; Yang M; Liu B; Chen W; Zhan YY; Zhang MQ; Cai JC; Zheng ZH; Lin SC; Li BA; Wu Q
    Gut; 2012 May; 61(5):714-24. PubMed ID: 21873734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CKIα ablation highlights a critical role for p53 in invasiveness control.
    Elyada E; Pribluda A; Goldstein RE; Morgenstern Y; Brachya G; Cojocaru G; Snir-Alkalay I; Burstain I; Haffner-Krausz R; Jung S; Wiener Z; Alitalo K; Oren M; Pikarsky E; Ben-Neriah Y
    Nature; 2011 Feb; 470(7334):409-13. PubMed ID: 21331045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A hypermorphic epithelial β-catenin mutation facilitates intestinal tumorigenesis in mice in response to compounding WNT-pathway mutations.
    Buchert M; Rohde F; Eissmann M; Tebbutt N; Williams B; Tan CW; Owen A; Hirokawa Y; Gnann A; Orend G; Orner G; Dashwood RH; Heath JK; Ernst M; Janssen KP
    Dis Model Mech; 2015 Nov; 8(11):1361-73. PubMed ID: 26398937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paracrine cyclooxygenase-2 activity by macrophages drives colorectal adenoma progression in the Apc
    Hull MA; Cuthbert RJ; Ko CWS; Scott DJ; Cartwright EJ; Hawcroft G; Perry SL; Ingram N; Carr IM; Markham AF; Bonifer C; Coletta PL
    Sci Rep; 2017 Jul; 7(1):6074. PubMed ID: 28729694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.
    Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S
    Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NHERF1/EBP50 Suppresses Wnt-β-Catenin Pathway-Driven Intestinal Neoplasia.
    Georgescu MM; Gagea M; Cote G
    Neoplasia; 2016 Aug; 18(8):512-23. PubMed ID: 27566107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex interplay between β-catenin signalling and Notch effectors in intestinal tumorigenesis.
    Peignon G; Durand A; Cacheux W; Ayrault O; Terris B; Laurent-Puig P; Shroyer NF; Van Seuningen I; Honjo T; Perret C; Romagnolo B
    Gut; 2011 Feb; 60(2):166-76. PubMed ID: 21205878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine-threonine Kinase Receptor-Associated Protein is a Critical Mediator of APC Mutation-Induced Intestinal Tumorigenesis Through a Feed-Forward Mechanism.
    Vu T; Datta A; Banister C; Jin L; Yuan G; Samuel T; Bae S; Eltoum IE; Manne U; Zhang B; Welner RS; Mitra K; Buckhaults P; Datta PK
    Gastroenterology; 2022 Jan; 162(1):193-208. PubMed ID: 34520730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCL9-2 promotes early stages of intestinal tumor progression.
    Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
    Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperation between the thyroid hormone receptor TRalpha1 and the WNT pathway in the induction of intestinal tumorigenesis.
    Kress E; Skah S; Sirakov M; Nadjar J; Gadot N; Scoazec JY; Samarut J; Plateroti M
    Gastroenterology; 2010 May; 138(5):1863-74. PubMed ID: 20114049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of TGF-beta or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotype.
    Roarty K; Baxley SE; Crowley MR; Frost AR; Serra R
    Breast Cancer Res; 2009; 11(2):R19. PubMed ID: 19344510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elucidating the interactions between the adhesive and transcriptional functions of beta-catenin in normal and cancerous cells.
    van Leeuwen IM; Byrne HM; Jensen OE; King JR
    J Theor Biol; 2007 Jul; 247(1):77-102. PubMed ID: 17382967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Pygo2 for Wnt/ß-catenin signaling activity during intestinal tumor initiation and progression.
    Talla SB; Brembeck FH
    Oncotarget; 2016 Dec; 7(49):80612-80632. PubMed ID: 27811361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
    Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
    Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypes of invasion in sporadic colorectal carcinomas related to aberrations of the adenomatous polyposis coli (APC ) gene.
    Prall F; Weirich V; Ostwald C
    Histopathology; 2007 Feb; 50(3):318-30. PubMed ID: 17257127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt signalling pathway in the serrated neoplastic pathway of the colorectum: possible roles and epigenetic regulatory mechanisms.
    Fu X; Li L; Peng Y
    J Clin Pathol; 2012 Aug; 65(8):675-9. PubMed ID: 22412046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PWD/Ph-Encoded Genetic Variants Modulate the Cellular Wnt/β-Catenin Response to Suppress
    Farrall AL; Lienhard M; Grimm C; Kuhl H; Sluka SHM; Caparros M; Forejt J; Timmermann B; Herwig R; Herrmann BG; Morkel M
    Cancer Res; 2021 Jan; 81(1):38-49. PubMed ID: 33154092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive changes in adherens junction structure during intestinal adenoma formation in Apc mutant mice.
    Carothers AM; Melstrom KA; Mueller JD; Weyant MJ; Bertagnolli MM
    J Biol Chem; 2001 Oct; 276(42):39094-102. PubMed ID: 11483600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.